Abstract
article 7 of the who code requires that the industry, that is, manufacturers and distributors, irrespective of any action taken by member states, is responsible “for monitoring their marketing practices conforming to the principles and aim of the Code and for taking steps to ensure that their conduct at every level conforms to them.”’ The code also proscribes, among other things, infant formula manufacturers and distributors from gaining market share by offering incentive bonuses or quotas set specifically for sale of breast-milk substitutes. However, the payment of bonus is permitted if it is “based on the overall sales by a company of other products marketed by it.”’ The industry representatives are disallowed to “perform educational functions in relation to pregnant women or mothers of young infants and young children.” However, they can be “used for other functions by the health care system at the request and written approval of the appropriate authority of the government concerned.”’ An evaluation of the code compliance by the infant formula industry is hampered by a variety of factors that makes all claims and counter-claims as to the industry compliance, or lack thereof, highly suspect.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sethi, S.P. (1994). Code Compliance By The Infant Formula Industry. In: Multinational Corporations and the Impact of Public Advocacy on Corporate Strategy. Issues in Business Ethics, vol 6. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1394-6_20
Download citation
DOI: https://doi.org/10.1007/978-94-011-1394-6_20
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4611-4
Online ISBN: 978-94-011-1394-6
eBook Packages: Springer Book Archive